PIPA5111120

ZFYVE19 Polyclonal Antibody, Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PIPA5111120-Each-of-1 In Stock ₹ 48,905.50

PIPA5111120 - Each of 1

₹ 48,905.50

In Stock

Quantity

1

Base Price: ₹ 48,905.50

GST (18%): ₹ 8,802.99

Total Price: ₹ 57,708.49

Antigen

ZFYVE19

Classification

Polyclonal

Formulation

PBS with 40% glycerol and 0.02% sodium azide; pH 7.2

Gene Accession No.

Q96K21

Gene Symbols

ZFYVE19

Immunogen

Recombinant Protein corresonding to Human ZFYVE19

Quantity

100 μL

Primary or Secondary

Primary

Target Species

Human

Product Type

Antibody

Isotype

IgG

Applications

Immunohistochemistry

Conjugate

Unconjugated

Gene

ZFYVE19

Gene Alias

1500041L05Rik; abscission/NoCut checkpoint regulator; ANCHR; MLL partner containing FYVE domain; MPFYVE; Zfyve19; Zinc finger FYVE domain-containing protein 19; zinc finger FYVE-type containing 19; zinc finger, FYVE domain containing 19

Host Species

Rabbit

Purification Method

Antigen affinity chromatography

Regulatory Status

RUO

Gene ID (Entrez)

84936

Content And Storage

Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.

Form

Liquid

Related Products

Img

Thermo Scientific

PIPA5111459

--

Img

Thermo Scientific

PIPA5111464

--

Img

Thermo Scientific

PIPA5111359

--

Img

Thermo Scientific

PIPA5111340

--

Img

Thermo Scientific

PIPA5111288

--

Img

Thermo Scientific

PIPA5111748

--

Img

Thermo Scientific

PIPA5111564

--

Img

Thermo Scientific

PIPA5111722

--

Description

  • Immunogen sequence: TRTQAQQTQD LLTQLAAEVA IDESWKGGGP AASLQNDLNQ GGPGSTNSKR QANWSLEEEK SRLLAEAALE LREENTRQER ILALAKRLAM L Key regulator of abscission step in cytokinesis: part of the cytokinesis checkpoint, a process required to delay abscission to prevent both premature resolution of intercellular chromosome bridges and accumulation of DNA damage
  • Together with CHMP4C, required to retain abscission-competent VPS4 (VPS4A and/or VPS4B) at the midbody ring until abscission checkpoint signaling is terminated at late cytokinesis
  • Deactivation of AURKB results in dephosphorylation of CHMP4C followed by its dissociation from ZFYVE19/ANCHR and VPS4 and subsequent abscission.